There are many causes of anemia as well as methods of its treatment. We offer a highly effective fetal stem cell treatment for anemia that addresses and impacts the pathogenetic component of the disease.
Stem cell therapy proved to be effective in treatment of primary and secondary anemia, including aplastic and hereditary anemias. An indication for transplantation of fetal stem cells in patients with an anemic syndrome is lack of response to standard treatment methods.
While pharmacological therapy is mainly aimed at stimulating the patient’s damaged bone marrow, and substitutive blood transfusions address red blood cell deficiency, stem cell therapy focuses on transplanting cells of erythropoietic series, or erythrocyte precursors, which increases the pool of cells responsible for hematopoies in the patient’s body. The number of erythrocytes and the levels of haemoglobin grow, which leads to significant improvement in patient’s quality of life and reduction in number and dosage of medications taken.
Positive results of fetal stem cell transplantation have been observed in treatment of anemia of various aetiology. They are especially demonstrative in cases of severe aplastic anemia. In all cases, high haemoglobin levels persisted for many years after 1–2 courses of fetal stem cell transplantation. The patients experienced no need for undergoing regular treatment at hospital haematology departments. No other existing methods are capable of yielding such results.
Stem cell therapy for patients with sickle cell anemia helps to reduce the frequency of crises, to soothe their course, as well as decrease the need for repeated transfusions of packed red cells that are associated not only with the well-known risks, but also are very stressful for the patient.
In case of hereditary anemias, stem cell therapy also has many benefits for the patient, but treatment effects decrease with time and successive courses of stem cell treatment are necessary.